Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
14.00
-0.32 (-2.23%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $519.76 million as of July 2, 2024. Its market cap has increased by 6.23% in one year.
Market Cap
519.76M
Enterprise Value
254.83M
1-Year Change
6.23%
Ranking
Category
Stock Price
$14.00
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $597.75M to $519.76M, a decrease of -13.05%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 483.40M | -3.99% |
| Dec 29, 2023 | 503.50M | 18.58% |
| Dec 30, 2022 | 424.60M | -20.55% |
| Dec 31, 2021 | 534.40M | -10.60% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 533.47M |
| SI-BONE | 532.78M |
| Third Harmonic Bio | 532.34M |
| Aveanna Healthcare Holdings | 530.97M |
| Y-mAbs Therapeutics | 530.10M |
| Lexeo Therapeutics | 528.44M |
| Heron Therapeutics | 527.29M |
| PepGen | 517.38M |